Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Advertise in Pharma in Focus

Advertising in Pharma in Focus delivers you:

  • Unique access to a $17 billion industry
  • High visibility with over 11,500 readers every working day
  • Great reaction with high click through rates
  • Unparalled contact via unique beyond-the-click services

For more information, ring 02 9938 4381

Approvals Action
Novartis' newest drug
First-ever oral SPMS drug Mayzent arrives.
Pipeline Monitor
New Takeda, AbbVie results
Positive data on vaccine and arthritis drug.
Top of the Hill
Dear PBAC, love patient
Patients are talking but who is listening?